Organisation paid for research Program year 2024 Source: CMS Open Payments

Meml Sloan Kettering Cancer Ctr

Neither a doctor nor a teaching hospital

Research payments

$351,421

101 payments

Through program year 2024, Meml Sloan Kettering Cancer Ctr is reported as receiving $351,421 in research payments, across 101 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$181,459	76
2023	Research	$61,502	14
2022	Research	$17,724	2
2021	Research	$25,000	1
2020	Research	$65,735	8

Breakdown

Who paid Research payments · program years 2020–2024

Janssen Research & Development, LLC $260,686 92 payments
Ethicon Endo-Surgery Inc. $65,735 8 payments
Ethicon Inc. $25,000 1 payment

Studies the money was for Research payments · program years 2020–2024

54767414Amy2009 $178,036 70 payments
Feasibility of trans-bronchial MW of normal lung tissue in porcine model NW-2018-05 $65,735 8 payments
68284528Mmy4002 $40,117 16 payments
NW-2018-05 Pre-clinical feasibility of trans-bronchial MW of normal lung tissue in porcine model $25,000 1 payment
A Phase 3 Randomized Placebo controlled Double blind Study of JNJ56021927 in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Subjects With Chemotherapy naive Metastatic Castration resistant Prostate Cancer mCRPC $22,801 2 payments
74494550Aml1003 $14,719 2 payments
17000139Blc2002 $4,680 1 payment
54767414Mmy3030 $334 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.